Cargando…
Antivirals for allosteric inhibition of Zika virus using a homology model and experimentally determined structure of envelope protein
OBJECTIVE: An approach to inhibiting enveloped flaviviruses is to deter the ability of the envelope protein(s) binding onto glycoproteins. In previous work, using a small ~100-amino acid homology model of Zika virus envelope protein (ZVEP), we proved the susceptibility of Zika virus to inhibition. I...
Autores principales: | Fernando, Sandun, Fernando, Teshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534091/ https://www.ncbi.nlm.nih.gov/pubmed/28754167 http://dx.doi.org/10.1186/s13104-017-2685-7 |
Ejemplares similares
-
Illustrating and homology modeling the proteins of the Zika virus
por: Ekins, Sean, et al.
Publicado: (2016) -
The Antiviral Drug Arbidol Inhibits Zika Virus
por: Fink, Susan L., et al.
Publicado: (2018) -
USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination
por: Wang, Yingchong, et al.
Publicado: (2021) -
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
por: Sacramento, Carolina Q., et al.
Publicado: (2017) -
Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice
por: Liang, Huabin, et al.
Publicado: (2018)